It should be noted that parenteral choline, inositol, and methionine combinations are not licensed medicines in the UK
Preclinical results are consistently positive in tissue repair contexts, but animal data cannot confirm human efficacy
The right dose depends on the indication, the patients weight and health history, and the prescribing providers clinical judgment
Hales, C
Preclinical studies have examined the peptide in models of gastrointestinal injury, epithelial disruption, and anastomosis healing where researchers analyze mucosal architecture, vascular integrity, and epithelial continuity following tissue damage [1]
Preclinical models suggest BPC-157 repairs esophageal tissue faster than omeprazole at 14 days, but PPIs have decades of human safety data and FDA approval BPC-157 has neither